Is Cronos Group Inc (CRON) a Good Buy in the Drug Manufacturers

Cronos Group Inc (CRON) is near the top in its industry group according to InvestorsObserver. CRON gets an overall rating of 47. That means it scores higher than 47 percent of stocks. Cronos Group Inc gets a 74 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 121 out of 148 industries.

CRON has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on CRON!

See Full CRON Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Cronos Group Inc Stock Today?

Cronos Group Inc (CRON) stock is trading at $1.97 as of 12:30 PM on Tuesday, Nov 28, a rise of $0.01, or 0.77% from the previous closing price of $1.95. The stock has traded between $1.91 and $1.97 so far today. Volume today is less active than usual. So far 622,492 shares have traded compared to average volume of 1,650,442 shares. Click Here to get the full Stock Report for Cronos Group Inc stock.